Asahi Kasei and Bluestar Studying mPPE

  • (c) mmmx/Shutterstock(c) mmmx/Shutterstock

Japan’s Asahi Kasei and China’s Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for producing a modified polyphenylene ether (mPPE) in China.

The facilities would include the intermediates 2,6-xylenol and polyphenylene ether (PPE). Following completion of detailed feasibility studies, the companies plan to make a final investment decision by March 2018.

The plans will be realized by a joint venture agreed in February of this year and will leverage Bluestar’s technology for 2,6-xylenol and PPE in combination with Asahi Kasei’s mPPE compounding technology and applications development capability.


Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.